Advancing Life Sciences Analytics with High-Performance Diffraction-Grating UV–VIS–NIR Spectroscopy

UV VIS NIR spectroscopy remains a cornerstone technique in life and health sciences, enabling sensitive, label free measurement of biomolecules, cellular responses, and complex biological matrices. As analytical needs expand toward higher throughput, greater spectral fidelity, and improved quantitation in challenging sample environments, traditional optical components must deliver elevated performance without compromising reliability. This presentation highlights a novel application of optimized ruled and holographic diffraction gratings engineered specifically to address emerging demands in biological and clinical spectroscopy.

Next-generation broadband, low-stray-light grating designs that enhance detection accuracy for assays involving nucleic acids, proteins, metabolites, and clinical biomarkers across 190–2500 nm are needed. Through refined ruling geometries, anti-scatter coatings (and ion beam etching), and thermally stable substrates, these gratings deliver improved spectral purity and higher signal to noise ratios, which are critical for applications such as pharmaceutical quality control, precision medicine, real time bioprocess monitoring, and non-invasive diagnostic spectroscopy. Enhanced groove profiles and efficiency balancing across UV, visible, and NIR regions enable a single spectrometer platform to support multiplexed workflows—from detecting subtle conformational changes in therapeutic proteins to monitoring tissue oxygenation and metabolic shifts in vivo.

Performance data from integrated systems show significant reductions in baseline drift, improved quantitation at low absorbance levels, and superior reproducibility in assays involving complex biological samples. These improvements directly translate to greater sensitivity in life science instrumentation including microplate readers, portable diagnostic analyzers, Raman hybrid systems, and NIR-based tissue sensors.

By pushing the optical performance boundaries of traditional diffraction gratings, this work demonstrates how incremental yet impactful innovations in mature optical technologies can drive major advances in biological and clinical spectroscopy. The result is a new class of robust, high-efficiency instruments capable of supporting the next generation of life and health science discoveries.

About the presenter
Paula Gullo is a seasoned marketing and sales leader with more than 35 years of experience supporting and driving growth for diffraction grating product lines. As a principal inside sales engineer, Gullo blends deep technical knowledge with strategic commercial expertise to shape product narratives, strengthen brand presence, and accelerate adoption across global markets.

Her extensive career in sales has been built on strong customer relationships, application-level insight, and a commitment to advancing optical and photonic innovation. She is recognized for her ability to translate complex product capabilities into clear, compelling value propositions that resonate with both technical and executive-level audiences.

Gullo holds an MBA, complementing her technical and commercial experience with strong business acumen, analytical rigor, and organizational leadership skills. In her current role, she partners closely with cross-functional teams—including product management, engineering, and sales—to launch high-impact initiatives, guide go-to-market strategy, and support revenue growth across her portfolio.

Known for her strategic mindset, collaborative approach, and dedication to mentoring rising talent, Gullo continues to play a pivotal role in shaping product marketing excellence within her organization. She is based in Rochester, NY.